Abstract
The Practical Guideline for the Management of Allergic Rhinitis in Japan was first published in 1993. After the COVID-19 pandemic, the current 10th edition was published in 2024. The most recent collection of evidence from the literature, such as the sustained post-treatment effect of sublingual immunotherapy on Japanese cedar pollinosis, was added to the revised guideline, which incorporates evidence-based medicine. In this revised guideline, a diagram illustrating the pathogenesis of allergic rhinitis and the mechanisms of action of various pharmacological treatments has been added. Also included is a diagram that shows the mechanism of action of allergen immunotherapy and a more detailed description of the oral allergy syndrome. The clinical question and answer section was also revised along with the introduction of new questions, such as: Does anti-IgE antibody treatment effectively reduce the symptoms of severe seasonal allergic rhinitis? Also updated was the evidence-based step-by-step strategy for treatment.
| Original language | English |
|---|---|
| Pages (from-to) | 426-441 |
| Number of pages | 16 |
| Journal | Auris Nasus Larynx |
| Volume | 52 |
| Issue number | 4 |
| DOIs | |
| State | Published - Aug 2025 |
Keywords
- Allergic rhinitis
- Guideline
- Mechanism of action of pharmacotherapy
- Pollinosis
- Sublingual immunotherapy
Fingerprint
Dive into the research topics of 'Practical guideline for the management of allergic rhinitis in Japan 2024'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver